Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-005129
Date:2020-01-24
Issuer: IRONWOOD PHARMACEUTICALS INC (IRWD)
Original Submission Date:

Reporting Person:

MCCOURT THOMAS A
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300 BOSTON, MA 02110

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2020-01-24 M 20,000 a $10.02 245,239 direct
CLASS A COMMON STOCK 2020-01-24 S 20,000 d $12.71 225,239 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 10.02 2020-01-24 deemed execution date M 20,000 (d) 2020-02-02 class a common stock 20,000 $10.02 0 direct
Footnotes
IDfootnote
f1 the reporting person acquired 280 shares of class a common stock under the issuer's employee stock purchase plan on december 31, 2019.
f2 this sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f3 the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $12.33 to $12.98, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f4 this option, granted as an annual performance award, is presently exercisable in full.
WhaleWisdom Logo

Elevate your investments